What is the recommended treatment for anxiety?

Treatment of Anxiety Disorders

For adults with anxiety disorders, initiate treatment with either selective serotonin reuptake inhibitors (SSRIs) or cognitive behavioral therapy (CBT) as first-line monotherapy, with the choice guided by patient preference, availability, and clinical presentation. 1, 2

Pharmacotherapy Recommendations

First-Line Medications

• SSRIs are the primary pharmacological treatment for anxiety disorders, including social anxiety disorder, generalized anxiety disorder, and panic disorder 1, 2, 3

  • Specific SSRIs with evidence include escitalopram, paroxetine, sertraline, and fluvoxamine 1, 2
  • These medications demonstrate moderate effect sizes with acceptable tolerability profiles 1

• SNRIs represent an equally effective first-line alternative, particularly venlafaxine, which has comparable efficacy to SSRIs 1, 2

Important Medication Considerations

• Continue pharmacotherapy for 6-12 months after achieving remission to prevent relapse 4, 5
• When discontinuing antidepressants, use slow tapering (>4 weeks) combined with psychological support rather than abrupt discontinuation or rapid tapering, as this approach significantly reduces relapse risk (RR 0.52 vs abrupt stopping) 6
• Benzodiazepines are NOT recommended for routine use due to addiction potential, despite their anxiolytic effects 3, 4, 5

Second-Line Options

• Pregabalin (calcium modulator) 4, 5
• Tricyclic antidepressants 3, 4
• Buspirone 4, 5
• Moclobemide (not available in all countries) 1, 4

Psychotherapy Recommendations

First-Line Psychotherapy

• Cognitive behavioral therapy (CBT) specifically designed for anxiety disorders is the psychological treatment with the highest level of evidence 1, 2, 3
  • For social anxiety disorder, use structured CBT based on the Clark and Wells model or Heimberg model 1
  • Individual CBT is prioritized over group therapy due to superior clinical and cost-effectiveness 1

CBT Structure and Components

• Deliver CBT as approximately 14 individual sessions of 60-90 minutes each over 4 months 1
• Essential components include:
  • Psychoeducation on the specific anxiety disorder 1
  • Cognitive restructuring to modify maladaptive thought patterns 1
  • Gradual exposure to feared situations (in vivo and imaginal) 1
  • Behavioral experiments to test anxious predictions 1

Alternative Psychotherapy Options

• If patients decline face-to-face CBT, offer supported self-help based on CBT principles 1
• Psychodynamic therapy may be considered when CBT is ineffective, unavailable, or when the informed patient prefers it despite lower evidence levels 3
• Second-generation mindfulness-based interventions show moderate effectiveness (effect size g=0.61 for anxiety), particularly self-compassion-focused approaches 7

Treatment Algorithm

Initial Treatment Selection

1. Assess patient preference after shared decision-making regarding pharmacotherapy vs psychotherapy 1, 2
2. Consider CBT availability and patient willingness to engage in structured psychological treatment 1
3. If pharmacotherapy is chosen, start with an SSRI (escitalopram, sertraline, paroxetine, or fluvoxamine) 1, 2
4. If psychotherapy is chosen, initiate disorder-specific CBT with a trained therapist 1

Managing Inadequate Response

• If initial SSRI is ineffective after adequate trial (typically 8-12 weeks at therapeutic dose), switch to another SSRI or SNRI 1, 3
• If monotherapy (either medication or psychotherapy) fails, switch to the alternative modality rather than immediately combining treatments 3
• Combination therapy (medication + psychotherapy) may be considered for treatment-resistant cases, though evidence for routine combination is insufficient 1

Special Populations

• For subsyndromal anxiety (symptoms not meeting full diagnostic criteria), begin with lifestyle modifications including regular exercise and stress reduction techniques before escalating to pharmacotherapy 8
• Exercise interventions show moderate effectiveness for anxiety symptoms (SMD -0.39), with resistance training particularly beneficial; shorter programs (<12 weeks) may be more practical 9
• For children and adolescents (<18 years), treatment approaches differ and require specialized guidelines 1

Critical Caveats

• These recommendations apply to adults ≥18 years without significant comorbid psychiatric disorders (e.g., schizophrenia, bipolar disorder, active substance use disorders) 1
• Exclude patients who are pregnant, at acute suicide risk, or have unstable medical conditions requiring specialized management 1
• Monitor treatment response regularly with validated instruments (e.g., GAD-7 for generalized anxiety) 8
• The evidence quality is generally low to moderate (GRADE 2C for pharmacotherapy, weak recommendations for psychotherapy), necessitating individualized clinical judgment 1
• Natural compounds like lavender oil extract (Silexan) may have a role in subsyndromal anxiety but require further validation 8